bpc 157 human clinical trial safety efficacy Wellness clinics promote the use of BPC-157 for recovery from injury or surgery. What do we know about it? It is effective in rodent models. Why might you think twice before using The Hidden Risks of BPC‑157:

With its established pharmacology, it stands as a useful tool alongside newer regenerative peptides

Note: A 4.5 mg weekly dose draws nearly the whole vial in a single injection

The Therapeutic Goods Administration (TGA) said it was "concerned" about an increase in the importation and supply of unapproved peptides, which were a "safety risk"

How This Works IGF-1 DES is a naturally-shortened variant of IGF-1: removing the N-terminal Gly-Pro-Glu tripeptide (and specifically the glutamate at position 3) greatly weakens its affinity for the IGF-binding proteins that normally sequester circulating IGF-1 [1]

I do feel like the B12 increased my energy level

Sign up for our newsletter or follow us on social media to stay updated on the latest deals